Page last updated: 2024-08-23

nitazoxanide and Local Neoplasm Recurrence

nitazoxanide has been researched along with Local Neoplasm Recurrence in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Hemmer, B; Höfler, J; Hornuss, C; Liedert, B; Roth, K; Selmaj, K; Wessels, H; Wiendl, H	1

Trials

1 trial(s) available for nitazoxanide and Local Neoplasm Recurrence

Article	Year
Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis: The Antelope Phase 3 Randomized Clinical Trial. JAMA neurology, 2023, 03-01, Volume: 80, Issue:3 Topics: Adult; Biosimilar Pharmaceuticals; Female; Gadolinium; Humans; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Neoplasm Recurrence, Local; Recurrence; Treatment Outcome	2023

Article

Year

Efficacy and Safety of Proposed Biosimilar Natalizumab (PB006) in Patients With Relapsing-Remitting Multiple Sclerosis: The Antelope Phase 3 Randomized Clinical Trial.

JAMA neurology, 2023, 03-01, Volume: 80, Issue:3

Topics: Adult; Biosimilar Pharmaceuticals; Female; Gadolinium; Humans; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Natalizumab; Neoplasm Recurrence, Local; Recurrence; Treatment Outcome

2023